Lercanidipine 20mg tablets

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Lercanidipine hydrochloride

থেকে পাওয়া:

Recordati Pharmaceuticals Ltd

এটিসি কোড:

C08CA13

INN (আন্তর্জাতিক নাম):

Lercanidipine hydrochloride

ডোজ:

20mg

ফার্মাসিউটিকাল ফর্ম:

Oral tablet

প্রশাসন রুট:

Oral

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 02060200; GTIN: 5060123270150

তথ্য লিফলেট

PACKAGE LEAFLET: INFORMATION FOR THE USER
_LERCANIDIPINE _
_HCL 10 _
_MG_
FILM-COATED TABLETS
_LERCANIDIPINE _
_HCL 20 _
_MG_
FILM-COATED TABLETS
lercanidipine hydrochloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING
THIS
MEDICINE
BECAUSE
IT
CONTAINS
IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If
you
have
any
further
questions,
ask
your
doctor
or
pharmacist.
-
This medicine has been prescribed for you only. Do not pass
it on to others. It may harm them, even if their signs of illness
are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this
leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Lercanidipine HCl is and what it is used for
2.
What
you
need
to
know
before
you
take
Lercanidipine HCl
3.
How to take Lercanidipine HCl
4.
Possible side effects
5.
How to store Lercanidipine HCl
6.
Contents of the pack and other information
1.
WHAT LERCANIDIPINE HCL IS AND WHAT IT IS USED FOR
Lercanidipine HCl, lercanidipine hydrochloride, belongs to a
group of medicines called Calcium
Channel Blockers (dihydropyridine derivatives)that lower blood
pressure.
Lercanidipine HCl is used to treat high blood pressure also
known as hypertension in adults over the age of 18 years (it is
not recommended for children under 18 years old).
2.
WHAT
YOU
NEED
TO
KNOW
BEFORE
YOU
TAKE
LERCANIDIPINE HCL
DO NOT TAKE LERCANIDIPINE HCL:
•
If
you
are
allergic
(hypersensitive)
to
lercanidipine
hydrochloride or to any other
ingredients of Lercanidipine HCl tablets.
•
If you are suffering from certain heart diseases:
o obstruction to flow of blood from the heart o untreated
heart failure
o unstable angina (chest discomfort occurring at rest or
progressively increasing) o within one month of heart
attack.
•
If you have severe liver problems.
•
If you have severe kidney problems or you are undergoing
dialysis.
•
If you are taking medicines that are inhibitors of the hepatic
metabolism,
such
a

পণ্য বৈশিষ্ট্য

OBJECT 1
LERCANIDIPINE HCL 20 MG FILM-COATED TABLETS
Summary of Product Characteristics Updated 28-Oct-2010 | Recordati
Pharmaceuticals Limited
1. Name of the medicinal product
LERCANIDIPINE HCl 20 mg film-coated tablets
2. Qualitative and quantitative composition
One tablet contains 20 mg of lercanidipine hydrochloride, which is
equivalent to 18.8 mg of
lercanidipine.
For excipients, see 6.1.
3. Pharmaceutical form
Film_-_coated tablet.
Pink, circular, biconvex tablets, scored on one side.
4. Clinical particulars
4.1 Therapeutic indications
Lercanidipine is indicated for the treatment of mild to moderate
essential hypertension.
4.2 Posology and method of administration
The recommended dosage is 10 mg orally once a day at least 15 minutes
before meals; the dose may be
increased to 20 mg depending on the individual patient's response.
Dose titration should be gradual, because it may take about 2 weeks
before the maximal antihypertensive
effect is apparent.
Some individuals, not adequately controlled on a single
antihypertensive agent, may benefit from the
addition of lercanidipine to therapy with a beta-adrenoceptor blocking
drug (atenolol), a diuretic
(hydrochlorothiazide) or an angiotensin converting enzyme inhibitor
(captopril or enalapril).
Since the dose-response curve is steep with a plateau at doses between
20-30 mg, it is unlikely that
efficacy will be improved by higher doses; whereas side effects may
increase.
_USE IN THE ELDERLY:_ although the pharmacokinetic data and clinical
experience suggest that no adjustment
of the daily dosage is required, special care should be exercised when
initiating treatment in the elderly.
_USE IN CHILDREN:_ since there is no clinical experience in patients
under the age of 18 years, use in children
is not currently recommended.
_USE IN RENAL OR HEPATIC DYSFUNCTION:_ special care should be
exercised when treatment is commenced in
patients with mild to moderate renal or hepatic dysfunction. Although
the usually recommended dose
schedule may be tolerated by these subgroups,